Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles.
Zhou T, Su H, Dash P, Lin Z, Dyavar Shetty BL, Kocher T, Szlachetka A, Lamberty B, Fox HS, Poluektova L, Gorantla S, McMillan J, Gautam N, Mosley RL, Alnouti Y, Edagwa B, Gendelman HE.
Zhou T, et al. Among authors: lamberty b.
Biomaterials. 2018 Jan;151:53-65. doi: 10.1016/j.biomaterials.2017.10.023. Epub 2017 Oct 15.
Biomaterials. 2018.
PMID: 29059541
Free PMC article.